Correlation Between HP and Phio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both HP and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HP and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HP Inc and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on HP and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HP with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HP and Phio Pharmaceuticals.
Diversification Opportunities for HP and Phio Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between HP and Phio is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding HP Inc and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and HP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HP Inc are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of HP i.e., HP and Phio Pharmaceuticals go up and down completely randomly.
Pair Corralation between HP and Phio Pharmaceuticals
Considering the 90-day investment horizon HP Inc is expected to under-perform the Phio Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, HP Inc is 15.48 times less risky than Phio Pharmaceuticals. The stock trades about 0.0 of its potential returns per unit of risk. The Phio Pharmaceuticals Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 272.00 in Phio Pharmaceuticals Corp on November 28, 2024 and sell it today you would lose (125.00) from holding Phio Pharmaceuticals Corp or give up 45.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
HP Inc vs. Phio Pharmaceuticals Corp
Performance |
| Timeline |
| HP Inc |
| Phio Pharmaceuticals Corp |
HP and Phio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HP and Phio Pharmaceuticals
The main advantage of trading using opposite HP and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HP position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.The idea behind HP Inc and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |